-
Signature
-
/s/ James R. Oehler, Attorney-in-Fact
-
Issuer symbol
-
HALO
-
Transactions as of
-
10 Sep 2025
-
Net transactions value
-
-$1,364,050
-
Form type
-
4
-
Filing time
-
11 Sep 2025, 17:09:57 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| LaBrosse Nicole |
SVP, CHIEF FINANCIAL OFFICER |
C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO |
/s/ James R. Oehler, Attorney-in-Fact |
11 Sep 2025 |
0001910662 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HALO |
Common Stock |
Options Exercise |
$136,041 |
+11,271 |
+35% |
$12.07 |
43,171 |
10 Sep 2025 |
Direct |
F1 |
| transaction |
HALO |
Common Stock |
Options Exercise |
$14,176 |
+1,135 |
+2.6% |
$12.49 |
44,306 |
10 Sep 2025 |
Direct |
F1 |
| transaction |
HALO |
Common Stock |
Sale |
$508,967 |
-6,760 |
-15% |
$75.29 |
37,546 |
10 Sep 2025 |
Direct |
F1, F2 |
| transaction |
HALO |
Common Stock |
Sale |
$1,005,300 |
-13,240 |
-35% |
$75.93 |
24,306 |
10 Sep 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
HALO |
Option to Purchase Common Stock |
Options Exercise |
$0 |
-11,271 |
-100% |
$0.000000 |
0 |
10 Sep 2025 |
Common Stock |
11,271 |
$12.07 |
Direct |
F1, F4 |
| transaction |
HALO |
Option to Purchase Common Stock |
Options Exercise |
$0 |
-1,135 |
-58% |
$0.000000 |
812 |
10 Sep 2025 |
Common Stock |
1,135 |
$12.49 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: